Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
Opioids are broad spectrum analgesics that are an integral part of the therapeutic armamentarium to combat pain in the clinical practice. Unfortunately, together with analgesia, a number of adverse effects can occur such as nausea, vomiting, constipation, gastrointestinal alterations and cognitive i...
Main Authors: | Laura Micheli, Lorenzo Di Cesare Mannelli, Elena Lucarini, Carmen Parisio, Alessandra Toti, Bruno Fiorentino, Maria Adele Rigamonti, Laura Calosi, Carla Ghelardini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.576624/full |
Similar Items
-
Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product
by: Pergolizzi, J, et al.
Published: (2018-02-01) -
Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications
by: Elena R. Beauregard, PharmD, BCPS, et al.
Published: (2024-04-01) -
Enhancement of Cisplatin Nephrotoxicity by Morphine and Its Attenuation by the Opioid Antagonist Naltrexone
by: Atefeh Aminian, et al.
Published: (2016-07-01) -
Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide
by: Goli Veeraindar, et al.
Published: (2012-03-01) -
Recent trends in opioid prescriptions in Korea from 2002 to 2015 based on the Korean NHIS-NSC cohort
by: Joungyoun Kim, et al.
Published: (2022-02-01)